IFG Advisory’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $308K | Buy |
+1,425
| New | +$273K | 0.01% | 741 |
|
|
2026
Q1 | – | Sell |
-1,425
| Closed | -$251K | – | 372 |
|
|
2025
Q4 | $251K | Buy |
+1,425
| New | +$233K | 0.01% | 681 |
|
|
2025
Q1 | – | Sell |
-1,471
| Closed | -$225K | – | 679 |
|
|
2024
Q4 | $225K | Buy |
+1,471
| New | +$248K | 0.01% | 613 |
|
|
2024
Q3 | – | Sell |
-1,510
| Closed | -$350K | – | 406 |
|
|
2024
Q2 | $350K | Buy |
+1,510
| New | +$328K | 0.02% | 474 |
|
|
2024
Q1 | – | Sell |
-1,779
| Closed | -$460K | – | 385 |
|
|
2023
Q4 | $460K | Buy |
1,779
+93
| +6% | +$22.8K | 0.03% | 378 |
|
|
2023
Q3 | $433K | Buy |
+1,686
| New | +$451K | 0.04% | 373 |
|
|
2023
Q2 | – | Sell |
-1,686
| Closed | -$469K | – | 335 |
|
|
2023
Q1 | $469K | Sell |
1,686
-38
| -2% | -$10.5K | 0.04% | 331 |
|
|
2022
Q4 | $477K | Hold |
1,724
| – | – | 0.05% | 320 |
|
|
2022
Q3 | $460K | Buy |
+1,724
| New | +$366K | 0.04% | 329 |
|
|
2022
Q1 | – | Sell |
-1,084
| Closed | -$260K | – | 493 |
|
|
2021
Q4 | $260K | Hold |
1,084
| – | – | 0.03% | 426 |
|
|
2021
Q3 | $306K | Hold |
1,084
| – | – | 0.03% | 396 |
|
|
2021
Q2 | $375K | Sell |
1,084
-48
| -4% | -$14.5K | 0.04% | 350 |
|
|
2021
Q1 | $316K | Sell |
1,132
-37
| -3% | -$9.98K | 0.04% | 384 |
|
|
2020
Q4 | $286K | Sell |
1,169
-123
| -10% | -$31.7K | 0.04% | 360 |
|
|
2020
Q3 | $366K | Buy |
1,292
+300
| +30% | +$83.7K | 0.06% | 286 |
|
|
2020
Q2 | $265K | Sell |
992
-17
| -2% | -$5.11K | 0.05% | 327 |
|
|
2020
Q1 | $319K | Buy |
1,009
+44
| +5% | +$13.4K | 0.07% | 256 |
|
|
2019
Q4 | $286K | Sell |
965
-72
| -7% | -$20K | 0.05% | 323 |
|
|
2019
Q3 | $241K | Sell |
1,037
-1,816
| -64% | -$423K | 0.05% | 344 |
|
|
2019
Q2 | $667K | Sell |
2,853
-56
| -2% | -$12.9K | 0.12% | 173 |
|
|
2019
Q1 | $687K | Sell |
2,909
-327
| -10% | -$103K | 0.13% | 154 |
|
|
2018
Q4 | $973K | Buy |
3,236
+131
| +4% | +$41.8K | 0.23% | 105 |
|
|
2018
Q3 | $1.1M | Buy |
3,105
+57
| +2% | +$19.6K | 0.21% | 112 |
|
|
2018
Q2 | $884K | Buy |
3,048
+70
| +2% | +$19.7K | 0.18% | 124 |
|
|
2018
Q1 | $815K | Sell |
2,978
-157
| -5% | -$48.7K | 0.18% | 126 |
|
|
2017
Q4 | $998K | Buy |
+3,135
| New | +$1.01M | 0.22% | 107 |
|
Other funds holding BIIB
IFG Advisory's BIIB Position: Q2 2026 in Review
IFG Advisory opened a new position in Biogen (BIIB) in Q2 2026: 1,425 shares worth $308K. The stake represents 0.01% of the portfolio and ranks #741 among its holdings. This is a return to the name: IFG Advisory previously reported a position in BIIB as recently as Q4 2025.
IFG Advisory first reported a position in BIIB in Q4 2017 and has held it in 26 quarters since. The position peaked at $1.1M in Q3 2018. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- IFG Advisory held 1,425 shares of Biogen worth $308K as of Q2 2026.
- Biogen was a new IFG Advisory position in Q2 2026.
- Biogen made up 0.01% of IFG Advisory's portfolio in Q2 2026, its #741 holding.
- IFG Advisory first reported a position in Biogen in Q4 2017 and has held it in 26 quarters since.
- IFG Advisory's Biogen position peaked at $1.1M in Q3 2018.
- 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.